Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division control protein 45 homolog (CDC45) is an essential eukaryotic protein required for the initiation and elongation phases of chromosomal DNA replication. In humans, CDC45 is a core component of the CMG helicase complex (composed of CDC45, MCM2-7, and GINS proteins), where it is indispensable for the assembly and activation of the replicative helicase machinery. The protein plays a pivotal role in the loading of DNA polymerase α onto chromatin and interacts with numerous DNA replication factors, including members of the MCM complex and origin recognition complex (ORC) proteins. CDC45's biological importance is highlighted by its highly conserved function from yeast to humans and its critical involvement during S-phase checkpoint response to DNA damage. CDC45 has no known intrinsic enzymatic activity and acts through physical association within multi-protein assemblies. Mutations or deregulation of CDC45 are associated with impaired DNA replication, cancer, and developmental disorders such as Meier-Gorlin syndrome
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division control protein 45 homolog (CDC45).